Evaluation of Gene Expression of Mirna 21 and 98 Effect on Liver Functions in Fibrotic Patients

Authors

  • Baraa Jalil Saeed Department of Biology, University of Al-Qadisiyha, Al Diwaniyah, Iraq
  • Wejdan Thamer Mahdi Department of Biology, University of Al-Qadisiyha, Al Diwaniyah, Iraq
  • Mohammed Abdulwahab Al-Askeri Department of Biology, University of Al-Qadisiyha, Al Diwaniyah, Iraq

DOI:

https://doi.org/10.31661/gmj.v14i.3833

Keywords:

Gene Expression; Mirna 21; Mirna 98; Liver Fibrosis; RT- PCR

Abstract

Background: Liver fibrosis is one of concerning outcomes of hepatitis with a complex interaction of different pathological processes including the epigenetics. MicroRNAs (miRNA) like miRNA 21 and 98 are recently being emphasized in era of epigenetics of liver diseases. The current study aims to evaluate liver function and the role of miRNA 21 and 98 in the occurrence of liver fibrosis. Materials and Methods: This was a case-control study comparing liver fibrosis patients with healthy adults with intact liver function as the control group. Laboratory and clinical tests were performed to evaluate liver function, and the diagnosis of viral hepatitis was confirmed using ELISA kits. Reverse transcription polymerase chain reaction (RT-PCR) was used to analyze the expression levels of microRNA 21 and 98, following the extraction of RNA from the samples. Results: Our study included 44 cases and 44 controls. Results revealed significant differences in demographic, clinical, and biochemical properties. Cases had higher mean BMI (34.36 ± 9.14 kg/m2, P=0.0486), higher levels of TSB, ALP, ALT, AST, and CRP, and lower albumin levels (P< 0.05 for all). Gene expression analysis showed higher miRNA 21 (1.14, P< 0.05) and lower miRNA 98 (1.68, P< 0.05) in cases compared to controls. Among case group, females had higher expression of miRNA 21 (1.082 ± 0.23) and miRNA 98 (1.895 ± 0.41) compared to males (P<0.05). Additionally, cases infected with HBV had higher expression of miRNA 21 (1.201 ± 0.31) and miRNA 98 (2.985 ± 0.56) compared to those infected with HCV (P<0.05). Conclusion: In conclusion, miRNA 21 and miRNA 98 might be associated with liver fibrosis; while the exact pathophysiological explanation reminds unclear.

References

Zhang CY, Yuan WG, He P, et al. Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets. World J Gastroenterol. 2016;22(48):10512-10522.

https://doi.org/10.3748/wjg.v22.i48.10512

PMid:28082803 PMCid:PMC5192262

Bataller R, Brenner DA. Liver fibrosis. J Clin Investig. 2005;115:209-218.

https://doi.org/10.1172/JCI24282

PMid:15690074 PMCid:PMC546435

Scott J, Jones AM, Piper Hanley K, Athwal VS. epidemiology, pathogenesis and management of liver disease in adults with cystic fibrosis. Alimentary pharmacology & therapeutics. 2022 Feb;55(4):389-400.

https://doi.org/10.1111/apt.16749

PMid:35048397

Fan HX, Tang H. Complex interactions between microRNAs and hepatitis B/C viruses. World J Gastroenterol. 2014; 20:13477-13492.

https://doi.org/10.3748/wjg.v20.i37.13477

PMid:25309078 PMCid:PMC4188899

Liu X, Ma H, Wu R, et al. Identification of Liver Fibrosis-Related MicroRNAs in Human Primary Hepatic Stellate Cells Using High-Throughput Sequencing. Genes (Basel). 2022;13(12):2201.

https://doi.org/10.3390/genes13122201

PMid:36553468 PMCid:PMC9778123

Wang Q, Wei S, Zhou H, et al. MicroRNA-98 Inhibits Hepatic Stellate Cell Activation and Attenuates Liver Fibrosis by Regulating HLF Expression. Front Cell Dev Biol. 2020;8:513.

https://doi.org/10.3389/fcell.2020.00513

PMid:32637414 PMCid:PMC7316892

Liu G, Friggeri A, Yang Y, et al. miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis. J Exp Med. 2010;207(8):1589-1597.

https://doi.org/10.1084/jem.20100035

PMid:20643828 PMCid:PMC2916139

Chau BN, Xin C, Hartner J, et al. MicroRNA-21 promotes fibrosis of the kidney by silencing metabolic pathways. Sci Transl Med. 2012;4(121):121ra18.

https://doi.org/10.1126/scitranslmed.3003205

PMid:22344686 PMCid:PMC3672221

Caviglia JM, Yan J, Jang MK, et al. MicroRNA-21 and Dicer are dispensable for hepatic stellate cell activation and the development of liver fibrosis. Hepatology. 2018;67(6):2414-2429.

https://doi.org/10.1002/hep.29627

PMid:29091291 PMCid:PMC5930143

Beermann J, Piccoli MT, Viereck J, Thum T. Non-coding RNAs in Development and Disease: Background, Mechanisms, and Therapeutic Approaches. Physiol Rev. 2016;96(4):1297-1325.

https://doi.org/10.1152/physrev.00041.2015

PMid:27535639

Patrick DM, Montgomery RL, Qi X, et al. Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice. J Clin Invest. 2010;120(11):3912-3916.

https://doi.org/10.1172/JCI43604

PMid:20978354 PMCid:PMC2964990

Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402-408.

https://doi.org/10.1006/meth.2001.1262

PMid:11846609

Kumarswamy R, Volkmann I, Thum T. Regulation and function of miRNA-21 in health and disease. RNA Biol. 2011;8(5):706-713.

https://doi.org/10.4161/rna.8.5.16154

PMid:21712654 PMCid:PMC3256347

Zhu H, Luo H, Li Y, et al. MicroRNA-21 in scleroderma fibrosis and its function in TGF-β-regulated fibrosis-related genes expression [published correction appears in . J Clin Immunol. 2013 Aug;33(6):1143-4.

https://doi.org/10.1007/s10875-013-9910-5

Ludwig N, Leidinger P, Becker K, et al. Distribution of miRNA expression across human tissues. Nucleic Acids Res. 2016;44(8):3865-3877.

https://doi.org/10.1093/nar/gkw116

PMid:26921406 PMCid:PMC4856985

Sarnow P, Jopling CL, Norman KL, et al. MicroRNAs: expression, avoidance and subversion by vertebrate viruses. Nat Rev Microbiol. 2006;4(9):651-659.

https://doi.org/10.1038/nrmicro1473

PMid:16912711

Damania P, Sen B, Dar SB, et al. Hepatitis B virus induces cell proliferation via HBx-induced microRNA-21 in hepatocellular carcinoma by targeting programmed cell death protein4 (PDCD4) and phosphatase and tensin homologue (PTEN). PLoS One. 2014;9(3):e91745.

https://doi.org/10.1371/journal.pone.0091745

PMid:24633222 PMCid:PMC3954734

Caviglia JM, Yan J, Jang MK, et al. MicroRNA-21 and Dicer are dispensable for hepatic stellate cell activation and the development of liver fibrosis. Hepatology. 2018;67(6):2414-2429.

https://doi.org/10.1002/hep.29627

PMid:29091291 PMCid:PMC5930143

Hou Z, Quan J. Hepatitis B virus X protein increases microRNA‑21 expression and accelerates the development of hepatoma via the phosphatase and tensin homolog/phosphoinositide 3‑kinase/protein kinase B signaling pathway. Mol Med Rep. 2017;15(5):3285-3291.

https://doi.org/10.3892/mmr.2017.6363

PMid:28339072

Bandiera S, Pernot S, El Saghire H, et al. Hepatitis C Virus-Induced Upregulation of MicroRNA miR-146a-5p in Hepatocytes Promotes Viral Infection and Deregulates Metabolic Pathways Associated with Liver Disease Pathogenesis. J Virol. 2016;90(14):6387-6400.

https://doi.org/10.1128/JVI.00619-16

PMid:27147737 PMCid:PMC4936128

Marquez RT, Bandyopadhyay S, Wendlandt EB, et al. Correlation between microRNA expression levels and clinical parameters associated with chronic hepatitis C viral infection in humans. Lab Invest. 2010;90(12):1727-1736.

https://doi.org/10.1038/labinvest.2010.126

PMid:20625373

Chen Y, Chen J, Wang H, et al. HCV-induced miR-21 contributes to evasion of host immune system by targeting MyD88 and IRAK1. PLoS Pathog. 2013;9(4):e1003248.

https://doi.org/10.1371/journal.ppat.1003248

PMid:23633945 PMCid:PMC3635988

Wang Q, Wei S, Zhou H, et al. MicroRNA-98 Inhibits Hepatic Stellate Cell Activation and Attenuates Liver Fibrosis by Regulating HLF Expression. Front Cell Dev Biol. 2020;8:513.

https://doi.org/10.3389/fcell.2020.00513

PMid:32637414 PMCid:PMC7316892

Ma Y, Yuan X, Han M, et al. miR-98-5p as a novel biomarker suppress liver fibrosis by targeting TGFβ receptor 1. Hepatol Int. 2022;16(3):614-626.

https://doi.org/10.1007/s12072-021-10277-5

PMid:35188624

Jiang T, Li M, Li Q, Guo Z, Sun X, Zhang X, et al. MicroRNA-98-5p Inhibits Cell Proliferation and Induces Cell Apoptosis in Hepatocellular Carcinoma via Targeting IGF2BP1. Oncol Res. 2017 Aug 7;25(7):1117-1127.

https://doi.org/10.3727/096504016X14821952695683

PMid:28244848 PMCid:PMC7841188

Fan YH, Ye MH, Wu L, et al. Overexpression of miR-98 inhibits cell invasion in glioma cell lines via downregulation of IKKε. Eur Rev Med Pharmacol Sci. 2015;19(19):3593-3604.

Siragam V, Rutnam ZJ, Yang W, et al. MicroRNA miR-98 inhibits tumor angiogenesis and invasion by targeting activin receptor-like kinase-4 and matrix metalloproteinase-11. Oncotarget. 2012;3(11):1370-1385.

https://doi.org/10.18632/oncotarget.717

PMid:23211491 PMCid:PMC3717799

Yang G, Zhang X, Shi J. MiR-98 inhibits cell proliferation and invasion of non-small cell carcinoma lung cancer by targeting PAK1. Int J Clin Exp Med. 2015;8(11):20135-20145.

Szabo G, Bala S. MicroRNAs in liver disease Nature reviews. Gastroenterology & hepatology. 2013; 10(9): 542-552.

https://doi.org/10.1038/nrgastro.2013.87

PMid:23689081 PMCid:PMC4091636

Downloads

Published

2025-03-17

How to Cite

Jalil Saeed, B., Mahdi, W. T., & Al-Askeri, M. A. (2025). Evaluation of Gene Expression of Mirna 21 and 98 Effect on Liver Functions in Fibrotic Patients. Galen Medical Journal, 14, e3833. https://doi.org/10.31661/gmj.v14i.3833

Issue

Section

Original Article